These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 32164319)

  • 1. The Susceptibility of Retinal Ganglion Cells to Optic Nerve Injury is Type Specific.
    Yang N; Young BK; Wang P; Tian N
    Cells; 2020 Mar; 9(3):. PubMed ID: 32164319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Susceptibility of Retinal Ganglion Cells to Glutamatergic Excitotoxicity Is Type-Specific.
    Christensen I; Lu B; Yang N; Huang K; Wang P; Tian N
    Front Neurosci; 2019; 13():219. PubMed ID: 30930737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effects of inhibitors of Acid-Sensing ion channels (ASICs) in optic nerve crush model in rodents.
    Stankowska DL; Mueller BH; Oku H; Ikeda T; Dibas A
    Curr Eye Res; 2018 Jan; 43(1):84-95. PubMed ID: 29111855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of ferroptosis promotes retina ganglion cell survival in experimental optic neuropathies.
    Guo M; Zhu Y; Shi Y; Meng X; Dong X; Zhang H; Wang X; Du M; Yan H
    Redox Biol; 2022 Dec; 58():102541. PubMed ID: 36413918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-4 protects retinal ganglion cells and promotes axon regeneration.
    Zuo Z; Fan B; Zhang Z; Liang Y; Chi J; Li G
    Cell Commun Signal; 2024 Apr; 22(1):236. PubMed ID: 38650003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celastrol supports survival of retinal ganglion cells injured by optic nerve crush.
    Kyung H; Kwong JM; Bekerman V; Gu L; Yadegari D; Caprioli J; Piri N
    Brain Res; 2015 Jun; 1609():21-30. PubMed ID: 25813825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAX-Depleted Retinal Ganglion Cells Survive and Become Quiescent Following Optic Nerve Damage.
    Donahue RJ; Maes ME; Grosser JA; Nickells RW
    Mol Neurobiol; 2020 Feb; 57(2):1070-1084. PubMed ID: 31673950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sigma-1R Protects Retinal Ganglion Cells in Optic Nerve Crush Model for Glaucoma.
    Li L; He S; Liu Y; Yorio T; Ellis DZ
    Invest Ophthalmol Vis Sci; 2021 Aug; 62(10):17. PubMed ID: 34406331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-time imaging of RGC death with a cell-impermeable nucleic acid dyeing compound after optic nerve crush in a murine model.
    Tsuda S; Tanaka Y; Kunikata H; Yokoyama Y; Yasuda M; Ito A; Nakazawa T
    Exp Eye Res; 2016 May; 146():179-188. PubMed ID: 27013099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aqp9 Gene Deletion Enhances Retinal Ganglion Cell (RGC) Death and Dysfunction Induced by Optic Nerve Crush: Evidence that Aquaporin 9 Acts as an Astrocyte-to-Neuron Lactate Shuttle in Concert with Monocarboxylate Transporters To Support RGC Function and Survival.
    Mori S; Kurimoto T; Miki A; Maeda H; Kusuhara S; Nakamura M
    Mol Neurobiol; 2020 Nov; 57(11):4530-4548. PubMed ID: 32748371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Together JUN and DDIT3 (CHOP) control retinal ganglion cell death after axonal injury.
    Syc-Mazurek SB; Fernandes KA; Wilson MP; Shrager P; Libby RT
    Mol Neurodegener; 2017 Oct; 12(1):71. PubMed ID: 28969695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SP1-mediated upregulation of LINGO-1 promotes degeneration of retinal ganglion cells in optic nerve injury.
    Wu Y; Zhan Z; Quan Y; Yang Y; Chen X; Liu L; Wu K; Yu M
    CNS Neurosci Ther; 2020 Oct; 26(10):1010-1020. PubMed ID: 32562344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmed cell death-1 is expressed in large retinal ganglion cells and is upregulated after optic nerve crush.
    Wang W; Chan A; Qin Y; Kwong JMK; Caprioli J; Levinson R; Chen L; Gordon LK
    Exp Eye Res; 2015 Nov; 140():1-9. PubMed ID: 26277582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AAV2-mediated GRP78 Transfer Alleviates Retinal Neuronal Injury by Downregulating ER Stress and Tau Oligomer Formation.
    Ha Y; Liu W; Liu H; Zhu S; Xia F; Gerson JE; Azhar NA; Tilton RG; Motamedi M; Kayed R; Zhang W
    Invest Ophthalmol Vis Sci; 2018 Sep; 59(11):4670-4682. PubMed ID: 30267089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Mobility Group Box 1 Inhibitor BoxA Alleviates Neuroinflammation-Induced Retinal Ganglion Cell Damage in Traumatic Optic Neuropathy.
    Peng J; Jin J; Su W; Shao W; Li W; Li Z; Yu H; Zheng Y; Zhong L
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in parvalbumin immunoreactive retinal ganglion cells and amacrine cells after optic nerve injury.
    Hong CJH; Siddiqui AM; Sabljic TF; Ball AK
    Exp Eye Res; 2016 Apr; 145():363-372. PubMed ID: 26601926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caspase-7: a critical mediator of optic nerve injury-induced retinal ganglion cell death.
    Choudhury S; Liu Y; Clark AF; Pang IH
    Mol Neurodegener; 2015 Aug; 10():40. PubMed ID: 26306916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rescue of retinal ganglion cells in optic nerve injury using cell-selective AAV mediated delivery of SIRT1.
    Ross AG; McDougald DS; Khan RS; Duong TT; Dine KE; Aravand P; Bennett J; Chavali VRM; Shindler KS
    Gene Ther; 2021 May; 28(5):256-264. PubMed ID: 33589779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptotic Retinal Ganglion Cell Death After Optic Nerve Transection or Crush in Mice: Delayed RGC Loss With BDNF or a Caspase 3 Inhibitor.
    Sánchez-Migallón MC; Valiente-Soriano FJ; Nadal-Nicolás FM; Vidal-Sanz M; Agudo-Barriuso M
    Invest Ophthalmol Vis Sci; 2016 Jan; 57(1):81-93. PubMed ID: 26780312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ecel1 Knockdown With an AAV2-Mediated CRISPR/Cas9 System Promotes Optic Nerve Damage-Induced RGC Death in the Mouse Retina.
    Sato K; Shiga Y; Nakagawa Y; Fujita K; Nishiguchi KM; Tawarayama H; Murayama N; Maekawa S; Yabana T; Omodaka K; Katayama S; Feng Q; Tsuda S; Nakazawa T
    Invest Ophthalmol Vis Sci; 2018 Aug; 59(10):3943-3951. PubMed ID: 30073365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.